Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF.

Mol Cell Biochem. 2012 Apr;363(1-2):257-68. doi: 10.1007/s11010-011-1178-6. Epub 2011 Dec 9.

PMID:
22160925
2.

A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.

Lee YJ, Wu CC, Li JW, Ou CC, Hsu SC, Tseng HH, Kao MC, Liu JY.

Oncotarget. 2016 Nov 29;7(48):78499-78515. doi: 10.18632/oncotarget.12100.

3.

Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism.

Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB, Morrison CD, Odunsi K.

PLoS One. 2014 Jan 7;9(1):e84941. doi: 10.1371/journal.pone.0084941. eCollection 2014.

4.

CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.

Chen YS, Wu MJ, Huang CY, Lin SC, Chuang TH, Yu CC, Lo JF.

PLoS One. 2011;6(11):e28053. doi: 10.1371/journal.pone.0028053. Epub 2011 Nov 28.

5.

Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.

Ma L, Lai D, Liu T, Cheng W, Guo L.

Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):593-602. doi: 10.1093/abbs/gmq067. Epub 2010 Aug 12.

PMID:
20705681
6.

Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.

Kim DK, Seo EJ, Choi EJ, Lee SI, Kwon YW, Jang IH, Kim SC, Kim KH, Suh DS, Seong-Jang K, Lee SC, Kim JH.

Exp Mol Med. 2016 Aug 26;48:e255. doi: 10.1038/emm.2016.73.

7.

Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.

Zhang J, Wang W, Qian L, Zhang Q, Lai D, Qi C.

Oncol Rep. 2015 Nov;34(5):2375-84. doi: 10.3892/or.2015.4213. Epub 2015 Aug 20.

PMID:
26323892
8.

Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.

Luo X, Dong Z, Chen Y, Yang L, Lai D.

Cell Prolif. 2013 Aug;46(4):436-46. doi: 10.1111/cpr.12038.

PMID:
23869765
9.

Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.

López J, Poitevin A, Mendoza-Martínez V, Pérez-Plasencia C, García-Carrancá A.

BMC Cancer. 2012 Jan 28;12:48. doi: 10.1186/1471-2407-12-48.

10.

Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.

Jiang H, Lin X, Liu Y, Gong W, Ma X, Yu Y, Xie Y, Sun X, Feng Y, Janzen V, Chen T.

Mol Med. 2012 Oct 24;18:1197-208. doi: 10.2119/molmed.2012.00075.

11.

Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.

Tang W, Ren A, Xiao H, Sun H, Li B.

Biomed Pharmacother. 2017 Jan;85:248-255. doi: 10.1016/j.biopha.2016.11.012. Epub 2016 Nov 28.

PMID:
27908706
12.

Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.

Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H, Farhat WA.

Mol Carcinog. 2016 May;55(5):537-51. doi: 10.1002/mc.22300. Epub 2015 Mar 1.

PMID:
25728352
13.

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S, Squire J, Park PC, Feilotter H.

BMC Cancer. 2012 Mar 19;12:91. doi: 10.1186/1471-2407-12-91.

14.

Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.

Nishi M, Akutsu H, Kudoh A, Kimura H, Yamamoto N, Umezawa A, Lee SW, Ryo A.

Oncotarget. 2014 Sep 30;5(18):8665-80.

15.

Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.

Wang X, Liu Y, Zhou K, Zhang G, Wang F, Ren J.

Int J Clin Exp Pathol. 2015 May 1;8(5):5105-12. eCollection 2015.

16.

EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.

Xu MH, Gao X, Luo D, Zhou XD, Xiong W, Liu GX.

PLoS One. 2014 Feb 6;9(2):e87893. doi: 10.1371/journal.pone.0087893. eCollection 2014.

17.

Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.

He QZ, Luo XZ, Wang K, Zhou Q, Ao H, Yang Y, Li SX, Li Y, Zhu HT, Duan T.

Cell Physiol Biochem. 2014;33(1):173-84. doi: 10.1159/000356660. Epub 2014 Jan 24.

18.

MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.

Nam EJ, Lee M, Yim GW, Kim JH, Kim S, Kim SW, Kim YT.

BMC Med Genomics. 2012 May 29;5:18. doi: 10.1186/1755-8794-5-18.

19.

OVCAR-3 spheroid-derived cells display distinct metabolic profiles.

Vermeersch KA, Wang L, Mezencev R, McDonald JF, Styczynski MP.

PLoS One. 2015 Feb 17;10(2):e0118262. doi: 10.1371/journal.pone.0118262. eCollection 2015.

20.

Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.

Ramgolam K, Lauriol J, Lalou C, Lauden L, Michel L, de la Grange P, Khatib AM, Aoudjit F, Charron D, Alcaide-Loridan C, Al-Daccak R.

PLoS One. 2011 Apr 15;6(4):e18784. doi: 10.1371/journal.pone.0018784.

Supplemental Content

Support Center